BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Staging
8 results:

  • 1. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.
    Semsar-Kazerooni K; Morand GB; Payne AE; da Silva SD; Forest VI; Hier MP; Pusztaszeri MP; Tamilia M; Payne RJ
    J Otolaryngol Head Neck Surg; 2022 Mar; 51(1):9. PubMed ID: 35246262
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BRAF
    Bakkar S; Macerola E; Aljarrah Q; Proietti A; Materazzi G; Basolo F; Miccoli P
    Updates Surg; 2019 Dec; 71(4):701-704. PubMed ID: 31586312
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.
    Goldner WS; Angell TE; McAdoo SL; Babiarz J; Sadow PM; Nabhan FA; Nasr C; Kloos RT
    Thyroid; 2019 Nov; 29(11):1594-1605. PubMed ID: 31469053
    [No Abstract]    [Full Text] [Related]  

  • 4. Mutational status of KRAS, nras, and BRAF in primary clear cell ovarian carcinoma.
    Zannoni GF; Improta G; Chiarello G; Pettinato A; Petrillo M; Scollo P; Scambia G; Fraggetta F
    Virchows Arch; 2014 Aug; 465(2):193-8. PubMed ID: 24889043
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pre-operative role of BRAF in the guidance of the surgical approach and prognosis of differentiated thyroid carcinoma.
    Danilovic DL; Lima EU; Domingues RB; Brandão LG; Hoff AO; Marui S
    Eur J Endocrinol; 2014 Apr; 170(4):619-25. PubMed ID: 24468978
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
    Pinto AE; Silva G; Banito A; Leite V; Soares J
    Oncol Rep; 2008 Oct; 20(4):913-9. PubMed ID: 18813835
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Thyroid carcinoma.
    Gillenwater AM; Weber RS
    Cancer Treat Res; 1997; 90():149-69. PubMed ID: 9367082
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Immunohistological study on ras and myc oncogene products in pancreatic cancer].
    Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.